Daily Archives: May 26, 2010

FDA’s Generic Drugs – FDA Tracker Status Update

 A month ago I was able to sit down with FDA's Deputy Commissioner Dr. Joshua Sharfstein to discuss the FDA's new effort at transparency and accountability called FDA Tracker, resulting in a podcast on the subject.  FDA Tracker is a … Continue reading

Posted in FDA Policy, Generic Drugs | Comments Off on FDA’s Generic Drugs – FDA Tracker Status Update